Gemfibrozil Impairs lmatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite

A. M. Filppula; A. Tornio; Mikko Niemi; P. J. Neuvonen; J. T. Backman

doi:10.1038/clpt.2013.92

Gemfibrozil Impairs lmatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite

A. M. Filppula, A. Tornio, Mikko Niemi, P. J. Neuvonen, J. T. Backman

Pharmacy

Research output: Contribution to journal › Article › Scientific › peer-review

25 Citations (Scopus)

Original language	English
Journal	Clinical Pharmacology & Therapeutics
DOIs	https://doi.org/10.1038/clpt.2013.92
Publication status	Published - 2013
MoE publication type	A1 Journal article-refereed

Access to Document

10.1038/clpt.2013.92

Cite this

@article{688dd4552a704921a180cb973ce7fdf7,

title = "Gemfibrozil Impairs lmatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite",

author = "Filppula, {A. M.} and A. Tornio and Mikko Niemi and Neuvonen, {P. J.} and Backman, {J. T.}",

year = "2013",

doi = "10.1038/clpt.2013.92",

language = "English",

journal = "Clinical Pharmacology & Therapeutics",

}

TY - JOUR

T1 - Gemfibrozil Impairs lmatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite

AU - Filppula, A. M.

AU - Tornio, A.

AU - Niemi, Mikko

AU - Neuvonen, P. J.

AU - Backman, J. T.

PY - 2013

Y1 - 2013

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000323686900024&KeyUID=WOS:000323686900024

U2 - 10.1038/clpt.2013.92

DO - 10.1038/clpt.2013.92

M3 - Article

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

ER -

Gemfibrozil Impairs lmatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite

Access to Document

Other files and links

Cite this